RhumbLine Advisers’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.17M | Sell |
|
|||||
|
2025
Q1 | $5.68M | Sell |
|
|||||
|
2024
Q4 | $6.71M | Sell |
|
|||||
|
2024
Q3 | $7.89M | Buy |
|
|||||
|
2024
Q2 | $8.49M | Sell |
|
|||||
|
2024
Q1 | $7.78M | Sell |
|
|||||
|
2023
Q4 | $10.1M | Buy |
|
|||||
|
2023
Q3 | $8.96M | Buy |
|
|||||
|
2023
Q2 | $8.1M | Buy |
|
|||||
|
2023
Q1 | $6.32M | Buy |
|
|||||
|
2022
Q4 | $6.24M | Buy |
|
|||||
|
2022
Q3 | $6.89M | Buy |
|
|||||
|
2022
Q2 | $5.72M | Buy |
|
|||||
|
2022
Q1 | $4.95M | Sell |
|
|||||
|
2021
Q4 | $4.25M | Buy |
|
|||||
|
2021
Q3 | $4.64M | Sell |
|
|||||
|
2021
Q2 | $5.57M | Sell |
|
|||||
|
2021
Q1 | $6.49M | Sell |
|
|||||
|
2020
Q4 | $8.58M | Sell |
|
|||||
|
2020
Q3 | $7.33M | Sell |
|
|||||
|
2020
Q2 | $9.42M | Buy |
|
|||||
|
2020
Q1 | $6.59M | Sell |
|
|||||
|
2019
Q4 | $8.54M | Buy |
|
|||||
|
2019
Q3 | $8.26M | Sell |
|
|||||
|
2019
Q2 | $8.91M | Sell |
|
|||||
|
2019
Q1 | $11.4M | Sell |
|
|||||
|
2018
Q4 | $7.66M | Sell |
|
|||||
|
2018
Q3 | $7.59M | Sell |
|
|||||
|
2018
Q2 | $6.24M | Buy |
|
|||||
|
2018
Q1 | $6.49M | Sell |
|
|||||
|
2017
Q4 | $7.63M | Sell |
|
|||||
|
2017
Q3 | $7.81M | Sell |
|
|||||
|
2017
Q2 | $8.04M | Sell |
|
|||||
|
2017
Q1 | $6.44M | Buy |
|
|||||
|
2016
Q4 | $7.39M | Buy |
|
|||||
|
2016
Q3 | $5.25M | Buy |
|
|||||
|
2016
Q2 | $3.18M | Buy |
|
|||||
|
2016
Q1 | $5.31M | Buy |
|
|||||
|
2015
Q4 | $8.11M | Buy |
|
|||||
|
2015
Q3 | $5.2M | Buy |
|
|||||
|
2015
Q2 | $7.24M | Sell |
|
|||||
|
2015
Q1 | $8.33M | Buy |
|
|||||
|
2014
Q4 | $6.9M | Sell |
|
|||||
|
2014
Q3 | $4.46M | Sell |
|
|||||
|
2014
Q2 | $4.03M | Sell |
|
|||||
|
2014
Q1 | $5.17M | Sell |
|
|||||
|
2013
Q4 | $4.96M | Buy |
|
|||||
|
2013
Q3 | $4.44M | Sell |
|
|||||
|
2013
Q2 | $3.19M | Buy |
|